Skip Nav Destination
Issues
1 July 2001
ISSN 1078-0432
EISSN 1557-3265
Editorials
Special Articles
Advances in Brief
Regular Articles
Clinical Trials
Anti-CD16/CD30 Bispecific Antibody Treatment for Hodgkin’s Disease: Role of Infusion Schedule and Costimulation with Cytokines1
Frank Hartmann; Christoph Renner; Wolfram Jung; Ligia da Costa; Sandra Tembrink; Gerhard Held; Alexandra Sek; Jochen König; Stefan Bauer; Michael Kloft; Michael Pfreundschuh
A Randomized Phase II Trial of Thalidomide, an Angiogenesis Inhibitor, in Patients with Androgen-independent Prostate Cancer1
William D. Figg; William Dahut; Paul Duray; Michael Hamilton; Anne Tompkins; Seth M. Steinberg; Elizabeth Jones; Ahalya Premkumar; W. Marston Linehan; Mary Kay Floeter; Clara C. Chen; Shannon Dixon; David R. Kohler; Erwin A. Krüger; Ed Gubish; James M. Pluda; Eddie Reed
A Phase I and Pharmacokinetic Study of 1843U89, a Noncompetitive Inhibitor of Thymidylate Synthase, in Patients with Advanced Solid Malignancies1
Garry Schwartz; Thomas R. Johnson; Andrew Goetz; Howard Burris; Leslie Smetzer; Thomas Lampkin; Jeffrey Sailstad; John A. Hohneker; Daniel D. Von Hoff; Eric K. Rowinsky
Phase I and Pharmacological Study of the Oral Matrix Metalloproteinase Inhibitor, MMI270 (CGS27023A), in Patients with Advanced Solid Cancer
Nicola C. Levitt; Ferry A. L. M. Eskens; Ken J. O’Byrne; David J. Propper; Louis J. Denis; Samantha J. Owen; Les Choi; John A. Foekens; Sue Wilner; Jeanette M. Wood; Motowo Nakajima; Denis C. Talbot; William P. Steward; Adrian L. Harris; Jaap Verweij
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology
Diagnosis of Pancreatic Adenocarcinoma by Detection of Human Telomerase Reverse Transcriptase Messenger RNA in Pancreatic Juice with Sample Qualification1
Keiichi Seki; Takeshi Suda; Yutaka Aoyagi; Satoshi Sugawara; Masaaki Natsui; Hirotaka Motoyama; Yoshio Shirai; Teruo Sekine; Hirokazu Kawai; Yusaku Mita; Nobuo Waguri; Takashi Kuroiwa; Masato Igarashi; Hitoshi Asakura
Aberrant Methylation of the Adenomatous Polyposis Coli (APC) Gene Promoter 1A in Breast and Lung Carcinomas1
Arvind K. Virmani; Asha Rathi; Ubaradka G. Sathyanarayana; Asha Padar; Chun Xian Huang; H. Thomas Cunnigham; Alfredo J. Farinas; Sara Milchgrub; David M. Euhus; Michael Gilcrease; James Herman; John D. Minna; Adi F. Gazdar
Experimental Therapeutics, Preclinical Pharmacology
In Vitro and in Vivo Antitumor Effect of the Anti-CD26 Monoclonal Antibody 1F7 on Human CD30+ Anaplastic Large Cell T-Cell Lymphoma Karpas 2991
Linus Ho; Ugur Aytac; L. Clifton Stephens; Kei Ohnuma; Gordon B. Mills; Kathryn S. McKee; Christopher Neumann; Ruth LaPushin; Fernando Cabanillas; James L. Abbruzzese; Chikao Morimoto; Nam H. Dang
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.